Description
Epigenetic activation or inactivation of genes plays a critical role in many important human diseases, especially in cancer. A major mechanism for epigenetic inactivation of the genes is methylation of CpG islands in genome DNA caused by DNA methyltransferases. Histone methyltransferases (HMTs) control or regulate DNA methylation through chromatin-dependent transcription repression or activation. HMTs transfer 1-3 methyl groups from S-adenosyl-L-methionine to the lysine and arginine residues of histone proteins. SET2 is a histone methyltransferase that catalyzes methylation of histone H3 at lysine 36 (H3-K36) in mammalian cells.H3-K36 tri-methylation is associated with transcriptionally active genes. Increased H3-K36 methylation is also found to be linked to the Sotos syndrome and leukemia-associated protein NSD1 and the Huntington"s disease protein HYPB. The H3-K36 tri-methylation can be changed by inhibiton or activation of HMTs.Thus quantitative detection of tri-methyl histone H3-K4 would provide useful information for better understanding epigenetic regulation of gene activation and for developing HMT-targeted drugs. The Tri-Methyl Histone H3-K36 Quantification Kit (Colorimetric) provides a tool for measuring tri-methylation of histone H3-K36